Tiziana Life Sciences Ltd (NASDAQ:TLSA). said it has received positive coverage in an article on Forbes which highlighted foralumab, its unique intranasal monoclonal antibody currently in clinical development to treat multiple sclerosis and other neurodegenerative diseases.
The biotechnology company said that foralumab is the world’s only fully human, anti-CD3 mAb in clinical development. Foralumab binds to the T cell receptor, dampening inflammation by modulating T cell function and suppressing effector features in multiple immune cell subsets.
Nano One Materials Corp (TSX:NANO, OTC:NNOMF) said it has received three new patents, one each in Taiwan, Korea and the US, taking its issued patents to a total of 27.
The patents will extend protection and add value to Nano One's One-Pot process technology for making lithium-ion battery cathode materials. They will also value to Nano One's sulfate-free, sustainable technology for the clean energy future, the company said.
Wellbeing Digital Sciences Inc has provided an update with respect to the management cease trade order (MCTO) issued by the British Columbia Securities Commission on January 31, 2023, in connection with the filing of the company’s audited annual financial statements for the year ended October 31, 2022, and the related management’s discussion and analysis and certifications. The company said it continues to work towards finalizing its Annual Filings and expects to be in a position to file on or before March 31, 2023. Since the default announcement, it noted that there has been no changes to the information contained in the announcement that would reasonably be expected to be material to investors.
Logiq, Inc. has announced the termination of its stock purchase agreement with Ionic Ventures and withdrawal of its S-1 financing facility. In a statement, Brent Suen, CEO of the provider of digital consumer acquisition solutions, commented: “We plan to embark on a decisive path of mergers and acquisitions, given that there is an amazing opportunity to increase our size, presence and revenue profile this year.”
Marble Financial Inc. told investors that it has closed a tranche of its non-brokered private placement of units, issuing 1.67 million units at $0.07 each for an aggregate subscription amount of $116,900. Each unit comprises a common share and one-half of a warrant, with each whole warrant exercisable to purchase a common share at $0.11 each for a period of two years. In connection with the tranche, it said an aggregate of 56,000 shares were issued as finder fees. All securities issued are subject to a hold period of four months and one day following issue. The company noted that certain insiders of the company purchased an aggregate of 950,000 units, representing approximately 57% of the total number of units issued.
Edison Lithium Corp. has announced that the TSX Venture Exchange has approved the extension of the expiry date of an aggregate of 9,700,000 common share purchase warrants by 24 months to February 26, 2025, an aggregate of 21,884,000 common share purchase warrants by 24 months to May 7, 2025, and an aggregate of 800,000 common share purchase warrants by 24 months to May 28, 2025. The company noted that these common share purchase warrants were issued under private placements which closed on February 26, 2021, May 7, 2021, and May 28, 2021, respectively. All other terms and conditions of the warrants, including the exercise prices, remain unchanged, it added.
Tiziana Life Sciences Ltd announced that it Gabriele Cerrone, its Chairman and Acting CEO, purchased 25,000 common shares at $0.58 per share, bringing his total holding to 38,640,737 common shares.
Plurilock Security Inc announced that Roland Sartorius is stepping down as CFO and Corporate Secretary after five and a half years to pursue other business interests. “I want to thank Roland for his many contributions over the past five and half years,” Ian Paterson, CEO of Plurilock, said on behalf of the board and team. “He was very instrumental in guiding the company's growth from revenues of $500,000 in 2017 to a current run rate of over $60 million. Roland leaves the company with a strong finance team and foundation that is well positioned for our next accelerated growth phase ahead."
Predictive Oncology Inc announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the company’s common stock held of record as of 5:00 p.m. Eastern Time on March 27, 2023.
Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Oil & Gas Virtual Investor Conference held on March 16th are now available for online viewing at https://bit.ly/3ZU8UBW.
NEO Battery Materials Ltd said its CEO Spencer Huh and Corporate Development Manager Danny Huh will participate in the Electric Vehicle & Auto Tech Virtual Conference, presented by Maxim Group and hosted by M-Vest, on Thursday, March 30, 2023. Both will participate in the company’s presentation at 10:00 AM ET. The conference will be live on M-Vest. Click here to register: https://m-vest.com/events/ev-and-auto-tech-03302023.